30-day FRN

45602

Federal Register / Vol. 82, No. 188 / Friday, September 29, 2017 / Notices

applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Minority Health and Health Disparities
Special Emphasis Panel; NIH Pathways to
Independence Award (K99/R00) Review.
Date: November 15, 2017.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Gateway Plaza, 7201 Wisconsin Avenue,
Suite 533, Bethesda, MD 20814
(Telepresence).
Contact Person: Richard C. Palmer, DRPH,
Health Scientist Administrator, National
Institute on Minority Health and Health
Disparities, National Institutes of Health,
6707 Democracy Blvd., Suite 800, Bethesda,
MD 20906, (301) 451–2432, richard.palmer@
nih.gov.
Dated: September 25, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–20860 Filed 9–28–17; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request Revision to
Identifying Experts in Prevention
Science Methods To Include on NIH
Review Panels, Office of Disease
Prevention (NIH ODP)
AGENCY:

National Institutes of Health,

HHS.
ACTION:

Notice.

In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below. This proposed
information collection was previously
published in the Federal Register on
July 6, 2017, page 31337 (82 FR 31337)
and allowed 60 days for public
comment. No public comments were
received. The purpose of this notice is
to allow an additional 30 days for public
comment.
DATES: Comments regarding this
information collection are best assured

asabaliauskas on DSKBBXCHB2PROD with NOTICES

SUMMARY:

VerDate Sep<11>2014

18:50 Sep 28, 2017

Jkt 241001

of having their full effect if received
within 30-days of the date of this
publication.
ADDRESSES: Written comments and/or
suggestions regarding the item(s)
contained in this notice, especially
regarding the estimated public burden
and associated response time, should be
directed to the: Office of Management
and Budget, Office of Regulatory Affairs,
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974, Attn: Desk Officer
for NIH.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Dr. Ranell Myles,
Public Health Analyst, NIH Office of
Disease Prevention, 6100 Executive
Blvd., Room 2B03, Bethesda, MD 20892
or call (301) 827–5579 or email your
request, including your address to
prevention@mail.nih.gov.
SUPPLEMENTARY INFORMATION: The Office
of Disease Prevention, National
Institutes of Health, may not conduct or
sponsor, and the respondent is not
required to respond to, an information
collection that has been extended,
revised, or implemented on or after
October 1, 1995, unless it displays a
currently valid OMB control number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection: Identifying
Experts in Prevention Science Methods
to Include on NIH Review Panels,—
REVISION, Office of Disease Prevention
(ODP), National Institutes of Health
(NIH) (OMB# 0925–0728, Expiration
date 12/31/2018)
Need and Use of Information
Collection: The Office of Disease
Prevention (ODP) is the lead Office at
the National Institutes of Health (NIH)
responsible for assessing, facilitating,
and stimulating research in disease
prevention and health promotion, and
disseminating the results of this
research to improve public health.
Prevention is preferable to treatment,
and research on disease prevention is an
important part of the NIH’s mission. The
knowledge gained from this research

PO 00000

Frm 00028

Fmt 4703

Sfmt 4703

leads to stronger clinical practice, health
policy, and community health
programs. ODP collaborates with the
NIH, other Department of Health and
Human Services (DHHS) agencies, and
other public and private partners to
achieve the Office’s mission and goals.
One of our priorities is to promote the
use of the best available methods in
prevention research and support the
development of better methods. One of
our strategies is to help the Center for
Scientific Review (CSR) identify experts
in prevention science methods to
include on their review panels. This
will strengthen the panels and improve
the quality of the prevention research
supported by the NIH. To identify
experts in prevention science methods,
we worked with our contractor, IQ
Solutions, Inc., to develop online
software which will allow us to collect
scientists’ names, contact information,
and resumes, as well as to have those
scientists identify their level of
expertise in a variety of prevention
science methods and content areas. The
information collected with this software
was used to create a web-based tool that
CSR staff can use to identify scientists
with expertise in specific prevention
science methods and content areas for
invitation to serve on one of the CSR
review panels. This system will also be
shared with review staff in the other
Institutes and Centers at the NIH, as
well as other DHHS agencies, to use in
the same way. Given our plans to create
an automated system for reviewer
information collection, we are now
seeking OMB approval for an extension
and the addition of more questions.
This PRA clearance request is for the
collection of additional data not
collected in the previously deployed
online software and survey including
additional study design topics, research
methods topics, content topics, as well
as the geographic region of research, and
the income category of the region/
country in which the research is
performed. The request also includes
asking researchers who have already
completed previous versions of the
survey to update their information
based on the revised additional topics.
OMB revision approval is requested
for 3 years. There are no costs to
respondents other than their time. The
total estimated annualized burden hours
are 1,550.

E:\FR\FM\29SEN1.SGM

29SEN1

45603

Federal Register / Vol. 82, No. 188 / Friday, September 29, 2017 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Type of respondents

Average
burden per
response
(in hours)

Total annual
burden hours

Investigators ...................................................................................................
Returning Investigators to update information ..............................................

3,120
1,000

1
1

25/60
15/60

1,300
250

Total ........................................................................................................

4,120

4,120

........................

1,550

Dated: September 24, 2017.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.

Dated: September 25, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.

[FR Doc. 2017–20885 Filed 9–28–17; 8:45 am]

[FR Doc. 2017–20859 Filed 9–28–17; 8:45 am]
BILLING CODE 4140–01–P

BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

National Institutes of Health

National Institutes of Health

National Human Genome Research
Institute; Notice of Closed Meeting

National Institute on Minority Health
and Health Disparities; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.

asabaliauskas on DSKBBXCHB2PROD with NOTICES

Number of
responses per
respondent

Name of Committee: National Institute on
Minority Health and Health Disparities
Special Emphasis Panel; ZMD1 DRI (J1) NIH
Support for Conferences and Scientific
Meetings (Parent R13).
Date: October 23, 2017.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Gateway Plaza, 533, 7201 Wisconsin Avenue,
Suite 533, Bethesda, MD 20814
(Telepresence).
Contact Person: Deborah Ismond, Ph.D.,
Scientific Review Officer, Division of
Scientific Programs, National Institute on
Minority Health and Health Disparities,
National Institutes of Health, 7201 Wisconsin
Ave., Suite 525, Bethesda, MD 20814, (301)
594–2704, ismonddr@mail.nih.gov.

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Inherited
Disease Research Access Committee.
Date: November 9, 2017.
Time: 11:30 a.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 3049,
5635 Fishers Lane, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Barbara J. Thomas, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Human Genome Research
Institute, National Institutes of Health, 5635
Fishers Lane, Ste. 4076, MSC 9306, Bethesda,
MD 20892–9306, 301–402–0838,
barbara.thomas@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: September 26, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–20988 Filed 9–28–17; 8:45 am]
BILLING CODE 4140–01–P

VerDate Sep<11>2014

18:50 Sep 28, 2017

Jkt 241001

PO 00000

Frm 00029

Fmt 4703

Sfmt 4703

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Planning NIDDK
Clinical Trials.
Date: November 9, 2017.
Time: 9:00 a.m. to 10:30 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Elena Sanovich, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7351, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, 301–594–8886,
sanoviche@mail.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK Program
Project (P01).
Date: November 14, 2017.
Time: 1:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Jason D. Hoffert, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7343, 6707 Democracy Boulevard,

E:\FR\FM\29SEN1.SGM

29SEN1